BIO vs INVX · rev $621.3M vs P/E 8.0, rev $483.9M
BIO (BIO) versus Innovex International, Inc (INVX) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Innovex International, Inc (INVX) is a oil & gas equipment & services company listed on US.
Latest reported BIO revenue for 2017-12-31 was $621.3M. Net income was $82.7M. Revenue was up 24.2% from 2017-03-31 to 2017-12-31. BIO currently screens at market cap $0.
Latest reported INVX revenue for 2026-06-30 was $483.9M. Net income was $8.4M. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
BIO currently screens at market cap $0. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
Not investment advice. Open the BIO and INVX stock pages for the full models.
Not investment advice.